Integer Holdings Corporation
ITGR
Helyezés a részvények között
#3856
Integer Holdings Corporation functions as a global leader in outsourced medical... Integer Holdings Corporation functions as a global leader in outsourced medical device manufacturing, maintaining operations across the United States, Puerto Rico, Costa Rica, and other international regions. The company organizes its business into two primary divisions: Medical and Non-Medical. Within its Medical segment, Integer delivers a broad array of devices and components essential for numerous advanced medical procedures. These solutions cater to areas such as interventional cardiology, structural heart conditions, heart failure management, peripheral and neurovascular interventions, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology. Their extensive product portfolio includes cardiac rhythm management devices like implantable pacemakers, defibrillators, cardiac monitors, leads, and heart failure therapies. They also produce neuromodulation devices, such as implantable spinal cord stimulators, alongside critical components like non-rechargeable batteries, feedthroughs, device enclosures, precision-machined parts, and lead sub-assemblies. Furthermore, Integer provides rechargeable battery systems and chargers. A comprehensive range of surgical instruments and components is also offered for arthroscopic, laparoscopic, and general surgery, encompassing items like harmonic scalpels, various blades and shavers, radio frequency and biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment parts, and phacoemulsification needles. Orthopedic offerings comprise specialized instruments for hip, knee, and spine surgeries, including reamers and chisels, among other general medical technologies. The Non-Medical segment concentrates on developing customized battery power and management systems, along with specialized battery solutions, designed for the energy, military, and environmental sectors. Integer primarily collaborates with multinational original equipment manufacturers (OEMs) and their affiliated subsidiaries, supporting their requirements across diverse markets, including cardiac, neuromodulation, orthopedics, vascular, advanced surgical, and portable medical applications. Established in 1970, Integer Holdings Corporation is headquartered in Plano, Texas.
Részvényárfolyam
$126.73
Utolsó szinkronizálás: 2026-10-20
Piaci kapitalizáció
$4.31B
Változás (1 nap)
-0.02%
Változás (1 év)
17.41%
Ország
US
Kereskedés Integer Holdings Corporation (ITGR)
Kategória
Healthcare
Bevétel a(z) Integer Holdings Corporation (ITGR) részvényhez
Bevétel ekkor: Jul 2026 TTM: $1.84B
Integer Holdings Corporation legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $1.84B. 2023 évben a vállalat $1.56B árbevételt ért el, amely növekedés a 2022 évben elért $1.33B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Integer Holdings Corporation bevételtörténete 2000 és 2026 között
Bevétel az év végén
| Év | Bevétel | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $1.84B | 7.26% |
| 2024 | $1.72B | 10.35% |
| 2023 | $1.56B | 16.85% |
| 2022 | $1.33B | 9.02% |
| 2021 | $1.22B | 13.75% |
| 2020 | $1.07B | -14.68% |
| 2019 | $1.26B | 3.55% |
| 2018 | $1.22B | 6.95% |
| 2017 | $1.14B | 5.63% |
| 2016 | $1.08B | 34.37% |
| 2015 | $800.41M | 16.38% |
| 2014 | $687.79M | 3.59% |
| 2013 | $663.95M | 2.75% |
| 2012 | $646.18M | 13.60% |
| 2011 | $568.82M | 6.64% |
| 2010 | $533.43M | 2.22% |
| 2009 | $521.82M | -4.54% |
| 2008 | $546.64M | 71.50% |
| 2007 | $318.75M | 17.56% |
| 2006 | $271.14M | 12.46% |
| 2005 | $241.10M | 20.48% |
| 2004 | $200.12M | -7.51% |
| 2003 | $216.37M | 29.33% |
| 2002 | $167.30M | 23.40% |
| 2001 | $135.58M | 38.64% |
| 2000 | $97.79M | 0.00% |
Hasonló cégek vagy versenytársak bevétele
| Vállalat | Bevétel | Bevételkülönbség | Ország |
|---|---|---|---|
| $46.59B | 2,430.20% |
US
|
|
| $35.48B | 1,827.27% |
IE
|
|
| $25.84B | 1,303.30% |
US
|
|
| $21.00B | 1,040.37% |
US
|
|
| - | - |
DE
|
